NCT00414869View on ClinicalTrials.gov

Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal Pressure

PHASE2TerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Portal Hypertension
Interventions
DRUG

NCX-1000

500 mg powder sachets to be taken as 1, 2, or 4 sachets twice daily, PO x 16 days

DRUG

Placebo

Inactive powder matching NCX-1000

Trial Locations (1)

08036

Hospital Clinic i Provincial de Barcelona, Barcelona

Sponsors
All Listed Sponsors
lead

Forest Laboratories

INDUSTRY